Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Will SLS-002 receive Fast Track designation from the FDA by December 31, 2025?  | Binary | 3 | 3 months ago | ||
Will SLS-002 demonstrate significant efficacy in the Phase II M-PACT trial for PTSD by June 30, 2025? | Binary | 2 | 3 months ago | ||
Will Seelos Therapeutics' stock price increase by another 50% after the M-PACT trial results by June 30, 2025? | Binary | 2 | 3 months ago | ||
What will be the outcome of the Phase II M-PACT trial for SLS-002 in treating PTSD by June 30, 2025? | Categorical | 2 | 3 months ago | ||
What will be Seelos Therapeutics' stock price at the end of Q2 2025? | Categorical | 2 | 3 months ago | ||
What will be the next significant partnership or agreement for Seelos Therapeutics by December 31, 2025? | Categorical | 2 | 3 months ago |